Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 2:16 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1825–1848 of 3,875 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: fast Clear all

Conditions: Diabetic Nephropathy
Interventions: CTP-499; Drug
Lead sponsor: Concert Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 38 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Gestational Diabetes Mellitus in Pregnancy, Pregnancy, High Risk
Interventions: Enhanced First Trimester GDM Screening, Routine Gestational Diabetes Screening; Diagnostic Test
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Pancreatic Solid Lesions
Interventions: Artificial Intelligence software ROSE; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 100 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Patient-reported Outcomes
Interventions: Arm A, Arm B; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: Not listed
Enrollment: 27,263 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Bone Infection, Joint Infection, Bone and Joint Infection
Interventions: Omadacycline Pill, Standard of Care; Drug
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Torrance, California

Conditions: Skin Diseases
Interventions: 3% Benzoyl Peroxide, 3% Benzoyl Peroxide Placebo, Neutrogena Rapid Clear®; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Years to 45 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: High Point, North Carolina

Conditions: Pheochromocytoma, Endocrine Disease, Endocrine Diseases
Interventions: ([18F]-DOPA), ([18F]-6F-DA); Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 3 Years to 120 Years
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2048
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Insulin Resistance, Atherosclerosis, Cardiovascular Disease, HIV/AIDS, HIV Infections
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 35 Years to 60 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Gestational Diabetes, Pregnancy, High Risk, Overweight and Obesity
Interventions: Intensive glycemic targets, Standard glycemic targets; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 828 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 5
States / cities: Birmingham, Alabama • Indianapolis, Indiana • Norman, Oklahoma + 2 more

Conditions: Kidney Failure, Chronic
Interventions: Lanthanum Carbonate, Sevelamer; Drug
Lead sponsor: Shire; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Cypress, California

Conditions: Patent Ductus Arteriosus
Interventions: feeding, fasting; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 23 Weeks to 33 Weeks
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 14
States / cities: San Francisco, California • San Jose, California • Chicago, Illinois + 11 more

Conditions: Psoriasis, Obesity
Interventions: Adipose tissue biopsy (fat biopsy); Procedure
Lead sponsor: Rockefeller University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Kidney Disease
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: Not listed
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mental Processes, Cognitive Change, Mood Change
Interventions: Placebo, Enovita Grape Seed Extract, Mirtoselect Bilberry Extract, Virtiva Plus Ginko Biloba Extract; Dietary Supplement
Lead sponsor: Applied Science & Performance Institute; Industry
Eligibility: 25 Years to 55 Years
Enrollment: 76 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Diet Habits, Cancer Prevention
Interventions: Time Restricted Eating, Group education, Counseling; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Spirometry test, Levalbuterol; Device · Drug
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 40 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obesity
Interventions: Mommio; Behavioral
Lead sponsor: Archimage, Inc.; Industry
Eligibility: 18 Years to 45 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity, Metabolic Syndrome
Interventions: Metabolic flexibility in the fasted state, Metabolic flexibility in euglycemic-hyperinsulinemic clamp, Metabolic flexibility in the metabolic chamber; Diagnostic Test · Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 20 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Diabetes Mellitus, Type 2
Interventions: Semaglutide, Placebo (semaglutide); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 50 Years and older
Enrollment: 9,651 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 91
States / cities: Montgomery, Alabama • Little Rock, Arkansas • Searcy, Arkansas + 79 more

Conditions: Sleep, Diet Modification
Interventions: Diet Quality; Other
Lead sponsor: University of Chicago; Other
Eligibility: 21 Years to 40 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Aging
Interventions: Experimental: Locomotor Learning; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 65 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Healthy
Interventions: Abrika Bupropion 150 mg XL Tablet, single dose, Wellbutrin XL® 150 mg Tablet, single dose; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Fort Myers, Florida

Conditions: Bacteremia
Interventions: Not listed
Lead sponsor: T2 Biosystems; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Healthy
Interventions: Ribavirin 200 mg tablets, COPEGUS™; Drug
Lead sponsor: Teva Pharmaceuticals USA; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003
U.S. locations: 2
States / cities: Houston, Texas

Search by objective public record fields.

Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499

Early Detection of Gestational Diabetes Mellitus in Pregnancy

Artificial Intelligence (AI) Cytopathology Trial

Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.

Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection

A Five Day Clinical Study to Examine the Effects of a Benzoyl Peroxide Treatment on Facial Acne Lesions

Diagnosis of Pheochromocytoma

Human Atherosclerotic Plaque Inflammation Imaged Using PDG-PET/CT

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers

Feeding During Ibuprofen or Indomethacin Treatment of Preterm Infants

Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects

Evaluation of New Test Method to Measure Kidney Function

The Effects of Mirtoselect®, Virtiva®, and Enovita® on Cognitive Performance and Mood States

Dietary Fiber and Time Restricted Eating

COPD Assessment and Management Bundle Versus Usual Care

Mommio: Training in Vegetable Parenting

Impact of Metabolic Flexibility on Changes in Metabolic Health

A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

Diet and Sleep Monitoring

Neural Underpinnings of Turning

A Relative Bioavailability Study of Bupropion XL 150 mg Tablets Under Fasting Conditions

Detecting Infections Rapidly and Easily for Bacteremia Trial (DIREBT)

Ribavirin 200 mg Tablets Under Fasting Conditions